|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,618.00 INR | +1.49% |
|
-1.42% | +5.86% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 37.64x | 16.53x | 3.12x | - | - | - | 1.14% | 4.59B | ||
| 33.78x | 20.73x | 0.63x | 12.37x | 24.91x | 26.52x | 0.57% | 1,062B | ||
| 28.59x | - | -1.55x | - | - | - | 2.09% | 619B | ||
| 32.06x | 362.92x | 0.14x | 7.3x | 15.18x | 15.81x | 2.84% | 431B | ||
| 20.32x | 7.27x | 1.71x | 4.82x | 11.94x | 13.24x | 2.74% | 358B | ||
| 21.87x | 6.16x | -9.53x | 5.66x | 14.12x | 14.97x | 2.84% | 293B | ||
| 20.44x | 4.59x | 1.06x | 4.22x | 11.99x | 12.66x | 2.09% | 247B | ||
| 25.38x | 17.74x | 2.1x | 6.71x | 11.89x | 15.38x | 2.49% | 219B | ||
| 13.28x | 5.63x | -3.3x | 4.8x | 10.09x | 11.88x | 3.83% | 200B | ||
| -40.65x | 8.08x | 0.28x | 5.84x | 32.95x | 55.64x | 2.52% | 162B | ||
| 15.84x | 1.7x | 0.73x | 3.19x | 8.17x | 9.18x | 6.54% | 149B | ||
| 11.43x | 5.39x | 0.18x | 3.21x | 8.4x | 9.02x | 3.94% | 131B | ||
| 28.53x | 5.35x | 2.65x | 8.23x | 18.75x | 19.44x | -.--% | 123B | ||
| 13.41x | 4.62x | 5.63x | 2.82x | 8.2x | 9.29x | 3.59% | 104B | ||
| 11.81x | 1.2x | -6.98x | 2.1x | 6.79x | 7.55x | 5.73% | 103B | ||
| 21.92x | 4.95x | 1.29x | 7.35x | 13.95x | 14.6x | 2.01% | 70.25B | ||
| 20.98x | 1.73x | -0.13x | 1.7x | 8.05x | 13.51x | 0.32% | 55.93B | ||
| 43.57x | 1.16x | 21.19x | 2.7x | 9.36x | 28.4x | 3.77% | 54.68B | ||
| 37.43x | 4.99x | 2.08x | 8.43x | 27.99x | 29.29x | 0.51% | 50.96B | ||
| 19.28x | 1.93x | 4.91x | 3.47x | 12.91x | 14.47x | 2.17% | 43.92B | ||
| Average | 20.84x | 25.41x | 1.31x | 5.27x | 14.20x | 17.82x | 2.59% | 224.13B | |
| Weighted average by Cap. | 23.59x | 50.07x | -0.09x | 7.22x | 16.71x | 19.22x | 2.26% |
- Stock Market
- Stocks
- GLAXO Stock
- Sector GlaxoSmithKline Pharmaceuticals Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















